24/05/2026
May is EDS Awareness month….
Blog 4 0f 4: Where Should the Money Go? A Patient-Centred Case for Research Triage
Where should the research money go?
A 2025 international survey of 3,906 hEDS patients documented a mean of 24 comorbid conditions and an average diagnostic delay of 22.1 years. MCAS was over 1,000 times more common in hEDS participants than in the general population.
During those 22 years of delay, patients are not waiting. They are spending — money, energy, and health they cannot afford to spend — on interventions recommended by well-meaning clinicians working with an inadequate evidence base.
This week’s blog makes the case for research triage in hEDS, POTS and MCAS — directing scarce research effort toward the questions that would produce the greatest clinical benefit for the greatest number of patients in the most practical timeframe. Four priority trials are identified. None of them are radical. All of them are overdue.
This is the final blog of “What We Don’t Know” — a four-part evidence audit of treatment for hEDS, POTS and MCAS.
Read the full piece: https://open.substack.com/pub/tracyfinnegan/p/the-system-and-the-patient-when-healthcare-180?r=2onzck&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true